ImmuCell Corporation Investor Presentation November 2023

ImmuCell Corporation presents its strategic business overview, financial performance, and market opportunities in this November 2023 investor presentation. The company focuses on subclinical mastitis treatment and related veterinary products, including its First Defense and Re-Tain product lines. The presentation covers manufacturing capacity, market demand, and financial results with forward-looking guidance.